Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ACLARA Announces Filing of Registration Statement.


Business Editors/Health &Medical Writers

MOUNTAIN VIEW, Calif.--(BW HealthWire)--Jan. 20, 2000

ACLARA BioSciences, Inc. announced today the filing of a Registration Statement on Form S-1 covering the initial public offering of its common stock.

The number of shares to be included in the proposed public offering and the expected price range of the shares were not included in the filing and will be determined at a later date by the company and the underwriters. All of the shares in the proposed offering are being sold by the company. Deutsche Banc Alex. Brown and Warburg Dillon Read Investment bank created by the 1997 merger of S.G. Warburg & Co. and Dillon, Read & Co. Subsequently renamed UBS Warburg and now part of UBS AG, where the Warburg name was eventually dropped.  LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
 are acting as joint book-running managers for the offering and U.S. Bancorp This article or section needs copy editing for grammar, style, cohesion, tone and/or spelling.
You can assist by [ editing it] now.
 Piper Jaffray Piper Jaffray & Co. (NYSE: PJC), often shortened to just Piper Jaffray or PiperJaffray, is a U.S. middle-market investment banking firm based in Minneapolis, Minnesota and is a focused on delivering financial advice, investment products and transaction execution  is co-manager for the offering.

ACLARA BioSciences, Inc. is a microfluidics, or lab-on-a-chip, company and is developing multiple products based on its proprietary technology that allow researchers to rapidly perform large numbers of chemical and biological measurements in a miniaturized, automated format. The company's plastic LabCard(TM) array chips are intended for use in the genomics and pharmaceutical drug screening markets.

Copies of the preliminary prospectus Preliminary Prospectus

A first draft registration statement filed by a firm prior to proceeding with an initial public offering of securities. The document, filed with the Securities & Exchange Commission, is intended to provide pertinent information to prospective shareholders
 relating to relating to relate prepconcernant

relating to relate prepbezüglich +gen, mit Bezug auf +acc 
 the offering may be obtained, when available, from:

Deutsche Banc Alex. Brown, One South Street, Baltimore, MD 21202 Warburg Dillon Read LLC, 299 Park Avenue, New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
, NY 10171 U.S. Bancorp Piper Jaffray, 222 South Ninth Street, Minneapolis,

MN 55402

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. The securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 20, 2000
Words:322
Previous Article:DSP Group Conference Call to be Broadcast by Investor Broadcast Network Over the Internet.
Next Article:Kenyon &Kenyon Makes Announcement.



Related Articles
Soane BioSciences Renamed ACLARA BioSciences.
Soane BioSciences Renamed ACLARA BioSciences.
ACLARA BioSciences Receives New Patent on Plastic Chips.
ACLARA Biosciences and PE Biosystems Sign Drug Screening Collaboration.
ACLARA BioSciences, Inc. IPO Priced at $21 Per Share.
ACLARA Asserts Federal Fraud Charges Against Caliper and Denies Infringement of Patents.
ACLARA Announces First Quarter 2000 Financial Results; Revenues up Over 100% as Company Meets Analyst Expectations.
ACLARA BioSciences and Cepheid Awarded $3.0 Million DARPA Grant.
ACLARA Announces Second Quarter 2000 Financial Results; Steady Progress Toward Product Launch.
eTag, you're it!

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles